About 7,000 people work at Biogen worldwide, according to its LinkedIn page, meaning it plans to reduce its workforce by more than than 10 percent.
The biotech recently secured full approval for Leqembi, an Alzheimer’s drug label it shares with Japan-based Eisai. It plans to launch the drug by the end of 2023.
The company has not submitted a WARN notice in Massachusetts, according to the state’s records, which were last updated July 21.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
